Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Nevirapine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nevirapine 400mg modified-release tablets
0503010B0AAAEAE
|
Nevirapine | Nevirapine | Infections | 2 |
|
Nevirapine 200mg tablets
0503010B0AAAAAA
|
Nevirapine | Nevirapine | Infections | 1 |
|
Nevirapine 100mg modified-release tablets
0503010B0AAADAD
|
Nevirapine | Nevirapine | Infections | No data available |
|
Nevirapine 50mg modified-release tablets
0503010B0AAACAC
|
Nevirapine | Nevirapine | Infections | No data available |
|
Nevirapine 50mg/5ml oral suspension
0503010B0AAABAB
|
Nevirapine | Nevirapine | Infections | No data available |
|
Viramune 100mg modified-release tablets
0503010B0BBADAD
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 200mg tablets
0503010B0BBAAAA
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 400mg modified-release tablets
0503010B0BBAEAE
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 50mg modified-release tablets
0503010B0BBACAC
|
Viramune | Nevirapine | Infections | No data available |
|
Viramune 50mg/5ml oral suspension
0503010B0BBABAB
|
Viramune | Nevirapine | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.